1. Targeted siRNA nanotherapeutics against breast and ovarian metastatic cancer: a comprehensive review of the literature
- Author
-
Abdus Subhan, Sara Aly Attia, and Vladimir P Torchilin
- Subjects
Ovarian Neoplasms ,Drug Delivery Systems ,Biomedical Engineering ,Medicine (miscellaneous) ,Humans ,General Materials Science ,Bioengineering ,Breast Neoplasms ,Female ,Development ,Neoplasm Metastasis ,RNA, Small Interfering ,Drug Resistance, Multiple - Abstract
Metastasis is considered the major cause of unsuccessful cancer therapy. The metastatic development requires tumor cells to leave their initial site, circulate in the blood stream, acclimate to new cellular environments at a remote secondary site and endure there. There are several steps in metastasis, including invasion, intravasation, circulation, extravasation, premetastatic niche formation, micrometastasis and metastatic colonization. siRNA therapeutics are appreciated for their usefulness in treatment of cancer metastasis. However, siRNA therapy as a single therapy may not be a sufficient option for control of metastasis. By combining siRNA with targeting, functional agents or small-molecule drugs have shown potential effects that enhance therapeutic effectiveness. This review addresses multidrug resistance and metastasis in breast and ovarian cancers and highlights drug-delivery strategies using siRNA therapeutics.
- Published
- 2021